3FR2
N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte Fatty-Acid Binding Protein (A-FABP) inhibitors
3FR2 の概要
エントリーDOI | 10.2210/pdb3fr2/pdb |
関連するPDBエントリー | 3FR4 3FR5 |
分子名称 | Fatty acid-binding protein, adipocyte, 9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid (3 entities in total) |
機能のキーワード | selective adipocyte fatty-acid binding protein (a-fabp) inhibitors, cytoplasm, lipid-binding, nucleus, phosphoprotein, polymorphism, transport, lipid binding protein |
由来する生物種 | Homo sapiens (human) |
細胞内の位置 | Cytoplasm: P15090 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 14914.07 |
構造登録者 | Barf, T.,Hammer, K.,Lehmann, F.,Haile, S.,Axen, E.,Medina, C.,Rondahl, L.,Uppenberg, J.,Svensson, S.,Lundb ck, T. (登録日: 2009-01-08, 公開日: 2009-03-10, 最終更新日: 2024-02-21) |
主引用文献 | Barf, T.,Lehmann, F.,Hammer, K.,Haile, S.,Axen, E.,Medina, C.,Uppenberg, J.,Svensson, S.,Rondahl, L.,Lundback, T. N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors. Bioorg.Med.Chem.Lett., 19:1745-1748, 2009 Cited by PubMed Abstract: Small molecule inhibitors of adipocyte fatty-acid binding protein (A-FABP) have gained renewed interest following the recent publication of pharmacologically beneficial effects of such inhibitors. Despite the potential utility of selective A-FABP inhibitors within the fields of metabolic disease, inflammation and atherosclerosis, there are few examples of useful A-FABP inhibitors in the public domain. Herein, we describe the optimization of N-benzyl-tetrahydrocarbazole derivatives through the use of co-crystal structure guided medicinal chemistry efforts. This led to the identification of a potent and selective class of A-FABP inhibitors as illustrated by N-benzyl-hexahydrocyclohepta[b]indole 30. PubMed: 19217286DOI: 10.1016/j.bmcl.2009.01.084 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.2 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード